2013-07-31 – Page 2 – China Stock Advice

JKS [JinkoSolar] F-3: (Original Filing)

[CALCULATION OF REGISTRATION FEE (1) Titleof Each Class of Securities to be (3)(4) Proposed Maximumgregate (4) Amount of (2) Ordinary shares, par value US$0.00002 per share Preferred shares Debt securities Total US$ 200,000,000 US$ 27,280 (1) (2) American depositary shares issuable upon deposit of the ordinary shares registered hereby have been or will be registered] [JinkoSolar INDENTUREted of [] [] TABLE OFNTENTS Page Article DEFINITIONS ANDORPORATION BY REFERENCE Section 1.1 Definitions. 1 Section 1.2 Other Definitions. 4 Section 1.3orporation by Reference of Trust Indenture Act. 5 Section 1.4 Rules ofnstruction. 5 Article THE SECURITIES Section 2.1 Issuable in Series.] [Our ref: JJH/660391-000001/6262239v2 JINKOSOLAR 1 Jingke Road Shangrao Economic Development Zone Jiangxi Province, 334100 Peoples Republic of China 31 July 2013 Dear Sirs JINKOSOLARmpany Registration Statementmmission Act Prospectus SharesSs We actyman Islandsunsel for Jinkosolar (the "] [July 31, 2013 JinkoSolar 1 Jingke Road Shangrao Economic Development Zone Jiangxi Province, 334100 People's Republic of China JinkoSolar Registration Statement on Form F-3 Ladies and Gentlemen: In thatnnection, we have reviewed the following: (a) The Registration Statement. (b) The Prospectus. (c) The Form of Indenture.] [JinkoSolarInc. RatioofEarningsto Fixed Charges YearendedDecember31, 2008 2009 2010 2011 2012 (InthousandsofRMB,exceptpercentage)mputation of Earnings:ome (loss) beforeome taxes and non-controlling interest 220,119 84,068 1,028,004 354,399 (1,552,717 ) Fixed charges 7,181 32,618 70,426 206,160 251,549 Amortization ofpitalized interest - 1 94 205 480 Non-controlling interest in pre-tax loss (income) of subsidiaries that have noturred fixed charges] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in this Registration Statement on FormF-3 of our reportted April 30, 2013 relating to the financial statements, which appears in JinkoSolar 's Annual Report on Form 20-F for the year ended December31, 2012. Wesonsent to the reference to us under the heading] [JinkoSolar 1 Jingke Road Dear Sirs, Yours faithfully,Hui Lawyers v351095_ex23-4.htm 7 EX-23.4]

By info| 2016-02-15T01:26:01+00:00 July 31st, 2013|Categories: Chinese Stocks, JKS, SEC Original|Tags: 0001481513, 2013-07-31, 3674, F-3, JKS, SEMICONDUCTORS and RELATED DEVICES|0 Comments

JKS [JinkoSolar] F-3: CALCULATION OF REGISTRATION FEE (1) Titleof Each Class

[CALCULATION OF REGISTRATION FEE (1) Titleof Each Class of Securities to be (3)(4) Proposed Maximumgregate (4) Amount of (2) Ordinary shares, par value US$0.00002 per share Preferred shares Debt securities Total US$ 200,000,000 US$ 27,280 (1) (2) American depositary shares issuable upon deposit of the ordinary shares registered hereby have been or will be registered] [JinkoSolar INDENTUREted of [] [] TABLE OFNTENTS Page Article DEFINITIONS ANDORPORATION BY REFERENCE Section 1.1 Definitions. 1 Section 1.2 Other Definitions. 4 Section 1.3orporation by Reference of Trust Indenture Act. 5 Section 1.4 Rules ofnstruction. 5 Article THE SECURITIES Section 2.1 Issuable in Series.] [Our ref: JJH/660391-000001/6262239v2 JINKOSOLAR 1 Jingke Road Shangrao Economic Development Zone Jiangxi Province, 334100 Peoples Republic of China 31 July 2013 Dear Sirs JINKOSOLARmpany Registration Statementmmission Act Prospectus SharesSs We actyman Islandsunsel for Jinkosolar (the "] [July 31, 2013 JinkoSolar 1 Jingke Road Shangrao Economic Development Zone Jiangxi Province, 334100 People's Republic of China JinkoSolar Registration Statement on Form F-3 Ladies and Gentlemen: In thatnnection, we have reviewed the following: (a) The Registration Statement. (b) The Prospectus. (c) The Form of Indenture.] [JinkoSolarInc. RatioofEarningsto Fixed Charges YearendedDecember31, 2008 2009 2010 2011 2012 (InthousandsofRMB,exceptpercentage)mputation of Earnings:ome (loss) beforeome taxes and non-controlling interest 220,119 84,068 1,028,004 354,399 (1,552,717 ) Fixed charges 7,181 32,618 70,426 206,160 251,549 Amortization ofpitalized interest - 1 94 205 480 Non-controlling interest in pre-tax loss (income) of subsidiaries that have noturred fixed charges] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in this Registration Statement on FormF-3 of our reportted April 30, 2013 relating to the financial statements, which appears in JinkoSolar 's Annual Report on Form 20-F for the year ended December31, 2012. Wesonsent to the reference to us under the heading] [JinkoSolar 1 Jingke Road Dear Sirs, Yours faithfully,Hui Lawyers v351095_ex23-4.htm 7 EX-23.4]

By info| 2016-02-15T01:29:07+00:00 July 31st, 2013|Categories: Chinese Stocks, JKS, Webplus ver|Tags: 0001481513, 2013-07-31, 3674, F-3, JKS, SEMICONDUCTORS and RELATED DEVICES|0 Comments

NTES [NetEase] 6-K: (Original Filing)

[NetEase,Inc. 26/F, SP Tower D Tsinghua Science Park Building 8 No.1 Zhongguancun East Road, Haidian District Beijing, Peoples Republic of China 100084 NOTICE OF 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 5, 2013 Important Notice Regarding the Availability of Proxy Materials for the 2013 Annual General Meeting of Shareholders to be], [NetEase,Inc. 26/F, SP Tower D Tsinghua Science Park Building 8 No.1 Zhongguancun East Road, Haidian District Beijing, Peoples Republic of China 100084 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 5, 2013 PROXY STATEMENT General We are soliciting proxies on behalf of our board of directors for use at the annual general], [THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF NETEASE,INC. FOR THE 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 5, 2013 1 [insert name] 2 3 . If no direction is made, this proxy will be voted FOR the following proposals: PROPOSAL NO. 1: Re-elect the following directors], [EX-99.4 a13-17329_1ex99d4.htm 5 EX-99.4]

By info| 2016-01-11T11:14:30+00:00 July 31st, 2013|Categories: Chinese Stocks, NTES, SEC Original|Tags: 0001110646, 2013-07-31, 6-K, 7389, NTES, SERVICES-BUSINESS SERVICES, NEC|0 Comments

NTES [NetEase] 6-K: NetEase,Inc. 26/F, SP Tower D Tsinghua Science Park

[NetEase,Inc. 26/F, SP Tower D Tsinghua Science Park Building 8 No.1 Zhongguancun East Road, Haidian District Beijing, Peoples Republic of China 100084 NOTICE OF 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 5, 2013 Important Notice Regarding the Availability of Proxy Materials for the 2013 Annual General Meeting of Shareholders to be], [NetEase,Inc. 26/F, SP Tower D Tsinghua Science Park Building 8 No.1 Zhongguancun East Road, Haidian District Beijing, Peoples Republic of China 100084 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 5, 2013 PROXY STATEMENT General We are soliciting proxies on behalf of our board of directors for use at the annual general], [THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF NETEASE,INC. FOR THE 2013 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON SEPTEMBER 5, 2013 1 [insert name] 2 3 . If no direction is made, this proxy will be voted FOR the following proposals: PROPOSAL NO. 1: Re-elect the following directors], [EX-99.4 a13-17329_1ex99d4.htm 5 EX-99.4]

By info| 2016-01-11T11:14:43+00:00 July 31st, 2013|Categories: Chinese Stocks, NTES, Webplus ver|Tags: 0001110646, 2013-07-31, 6-K, 7389, NTES, SERVICES-BUSINESS SERVICES, NEC|0 Comments

CO [China Cord Blood] 20-F: (Original Filing)

[TABLE OF CONTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financial data 4 B. Capitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors 7 ITEM 4. INFORMATION ON THE COMPANY 36] [Guangzhou City Real Estate Property Purchase Agreement Seller (Party A): Guangzhou Hezhong CD Manufacturing Co., Ltd. Legal Representative: ZHU Suifeng Buyer (Party B): Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Legal Representative: ZHENG Ting Article I Party A desires to transfer the real estate property it owns, including the land use right to the surrounding public green area and road] [Hundsun (Hangzhou) Science & Technology Park Property Transfer Agreement Contract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Co., Ltd. Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Co., Ltd. Legal Representative: DENG Yue Article I Background of the Construction Project Party A entered into an agreement “State Construction Land Use Right Transfer Contract” (contract] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013 Albert Chen Chief Financial Officer (Principal Financial and Accounting Officer)] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors China Cord Blood Corporation: Hong Kong, China July 31, 2013]

By info| 2016-02-29T13:21:19+00:00 July 31st, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: 0001467808, 20-F, 2013-07-31, 6770, BLANK CHECKS, CO|0 Comments

CO [China Cord Blood] 20-F: TABLE OF CONTENTS PART I 4 ITEM 1.

[TABLE OF CONTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financial data 4 B. Capitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors 7 ITEM 4. INFORMATION ON THE COMPANY 36] [Guangzhou City Real Estate Property Purchase Agreement Seller (Party A): Guangzhou Hezhong CD Manufacturing Co., Ltd. Legal Representative: ZHU Suifeng Buyer (Party B): Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Legal Representative: ZHENG Ting Article I Party A desires to transfer the real estate property it owns, including the land use right to the surrounding public green area and road] [Hundsun (Hangzhou) Science & Technology Park Property Transfer Agreement Contract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Co., Ltd. Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Co., Ltd. Legal Representative: DENG Yue Article I Background of the Construction Project Party A entered into an agreement “State Construction Land Use Right Transfer Contract” (contract] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013 Albert Chen Chief Financial Officer (Principal Financial and Accounting Officer)] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors China Cord Blood Corporation: Hong Kong, China July 31, 2013]

By info| 2016-02-29T13:22:53+00:00 July 31st, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: 0001467808, 20-F, 2013-07-31, 6770, BLANK CHECKS, CO|0 Comments

OIIM [O2MICRO INTERNATIONAL] 6-K: (Original Filing)

[O2Micro Reports Second Quarter 2013 Financial Results 2 ® GEORGE TOWN, Grand Cayman, July 31, 2013 (GLOBE NEWSWIRE) -- O Financial Highlights for the Second Quarter ending June 30, 2013 2 O GAAP net loss was $4.4 million in Q2 2013. This compares to a GAAP net loss of $5.1 million in the first quarter of 2013 and a GAAP]

By info| 2016-03-01T22:08:22+00:00 July 31st, 2013|Categories: Chinese Stocks, OIIM, SEC Original|Tags: 0001095348, 2013-07-31, 3674, 6-K, OIIM, SEMICONDUCTORS and RELATED DEVICES|0 Comments

OIIM [O2MICRO INTERNATIONAL] 6-K: O2Micro Reports Second Quarter 2013 Financial Results 2

[O2Micro Reports Second Quarter 2013 Financial Results 2 ® GEORGE TOWN, Grand Cayman, July 31, 2013 (GLOBE NEWSWIRE) -- O Financial Highlights for the Second Quarter ending June 30, 2013 2 O GAAP net loss was $4.4 million in Q2 2013. This compares to a GAAP net loss of $5.1 million in the first quarter of 2013 and a GAAP]

By info| 2016-03-01T22:09:05+00:00 July 31st, 2013|Categories: Chinese Stocks, OIIM, Webplus ver|Tags: 0001095348, 2013-07-31, 3674, 6-K, OIIM, SEMICONDUCTORS and RELATED DEVICES|0 Comments

CO [Chinard Bloodrp] 20-F: (Original Filing)

[TABLE OFNTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financialta 4 B.pitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors] [Guangzhou City Real Estate Property Purchasereement Seller (Party A):Guangzhou Hezhong CD Manufacturing Legal Representative:ZHU Suifeng Buyer (Party B):Guangzhou Municipality Tianhe Nuoya Bio-engineering Legal Representative:ZHENG Ting Article IParty A desires to transfer the real estate property it owns,luding the land use right to the surrounding public green area and road (See Property Layout Plan attached for] [Hundsun (Hangzhou)ience & Technology Park Property Transferreementntract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Legal Representative: DENG Yue Article IBackground of thenstruction Project Party A entered into anreement Statenstruction Land Use Right Transferntract (contract No. 3301102009A21063) with Hangzhou Municipal Bureau of] [List of Subsidiaries Name Jurisdiction Chinard Blood Servicesrporationyman Islands China Stem Cellss Limitedyman Islands Beijing Jiachenhong Biological Technologies Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Peoples Republic of China Zhejiang Lukou Biotechnology Peoples Republic of China China Stem Cells (East)mpany Limited] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification I,bert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification CHINARD BLOODRPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013bert Chen Chief Financial Officer (Principal Financial and Accounting Officer) v349858_ex13-1.htm 7 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Chinard Bloodrporation: Hong Kong, China July 31, 2013 v349858_ex15-1.htm 8 EX-15.1]

By info| 2016-02-04T15:54:01+00:00 July 31st, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: 0001467808, 20-F, 2013-07-31, 6770, BLANK CHECKS, CO|0 Comments

HIHO [HIGHWAY] 6-K: (Original Filing)

[NEWS RELEASE CONTACT: Gary S. Maier Maier & Company, Inc. (310) 471-1288 HIGHWAY HOLDINGS REPORTS FISCAL 2014 FIRST QUARTER RESULTS HONG KONG —July 29, 2013 — Nasdaq: HIHO Net sales for the fiscal first quarter increased 11 percent to $5.87 million from $5.27 million a year earlier. Net income for the same period increased 16.3 percent to $150,000, or $0.04]

By info| 2016-03-09T01:29:37+00:00 July 31st, 2013|Categories: Chinese Stocks, HIHO, SEC Original|Tags: 0001026785, 2013-07-31, 3490, 6-K, HIHO, MISCELLANEOUS FABRICATED METAL PRODUCTS|0 Comments